Home > Boards > US Listed > Biotechs > BrainStorm Cell Therapeutics Inc. (BCLI)

Agreed that is a clear factor too. And

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Spideyboy Member Profile
 
Followed By 4
Posts 586
Boards Moderated 0
Alias Born 04/07/08
160x600 placeholder
BrainStorm’s NurOwn® Phase 3 ALS Clinical Trial Now Fully Enrolled GlobeNewswire Inc. - 10/11/2019 1:00:00 AM
BrainStorm Announces Notice of US Patent Allowance for NurOwn® Cellular Therapeutic Technology Platform GlobeNewswire Inc. - 10/7/2019 8:04:26 AM
BrainStorm Cell Therapeutics to Present NurOwn® Phase 2 Biomarker Data at North East Amyotrophic Lateral Sclerosis (NEALS) 1... GlobeNewswire Inc. - 10/2/2019 6:45:00 AM
BrainStorm Cell Therapeutics Announces Support for FDA Guidelines on ALS Drug Development GlobeNewswire Inc. - 9/27/2019 4:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/9/2019 8:01:47 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/9/2019 8:01:32 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 9/9/2019 8:01:03 AM
BrainStorm Strengthens Senior Executive Management Team with the Appointment of Preetam Shah, Ph.D., M.B.A., as Chief Financi... GlobeNewswire Inc. - 9/9/2019 1:00:00 AM
BrainStorm Cell Therapeutics to Present Late Breaking News ePoster at the 35th ECTRIMS Congress GlobeNewswire Inc. - 9/6/2019 1:50:00 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 9/3/2019 6:01:01 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/30/2019 5:03:19 PM
Prospectus Filed Pursuant to Rule 424(b)(1) (424b1) Edgar (US Regulatory) - 8/30/2019 5:02:28 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 8/16/2019 5:18:25 PM
BrainStorm Announces Financial Results for the Second Quarter of 2019 and Provides a Corporate Update GlobeNewswire Inc. - 8/13/2019 7:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/13/2019 6:05:47 AM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 8/9/2019 5:10:20 PM
BrainStorm Cell Therapeutics to Announce Second Quarter Financial Results and Provide a Comprehensive Corporate Update GlobeNewswire Inc. - 8/5/2019 1:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 8/2/2019 5:02:36 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/2/2019 9:30:43 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/26/2019 5:04:29 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/26/2019 5:04:06 PM
Third Clinical Site Initiated for BrainStorm Cell Therapeutic’s Phase 2 Progressive MS Study GlobeNewswire Inc. - 7/2/2019 8:15:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/11/2019 5:03:08 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/11/2019 5:03:07 PM
BrainStorm Presents Poster at Consortium of Multiple Sclerosis Centers (CMSC) 33rd Annual Meeting GlobeNewswire Inc. - 5/31/2019 1:00:00 AM
Spideyboy   Saturday, 05/04/19 08:29:14 AM
Re: midastouch017 post# 2508
Post # of 2560 
Agreed that is a clear factor too. And i completely agree that one cannot say for sure.

However when you see the footage of Mark Bedwell who according to the facebook video Matt Bellina put up, given Mark was "struggling to walk", to running laps in the FDA headquarters after 3 courses of Nurown, either that is the treatment or that is one heck of a placebo.

It is interesting that since the last con-call where management mentioned about the inability to comment about the social media posting for entirely correct reasons, that the video has been removed by Matt. I assume this would be to slow the excitement around the posts which were becoming a burden on the number of communications received by the FDA team and Brainstorm around the trial.

This type of situation is akin to what we are seeing in the Pluristem CLI trial. The images the KOL provided were astounding, and his comments are similar in that, while he said this is a double blind trial, he's never seen such wounds spontaneous heal, so as he said there, either it's the treatment or an astounding placebo.



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist